Revenue: As of FY2026 Q3, the actual value is USD 5.004 M, missing the estimate of USD 5.256 M.EPS: As of FY2026 Q3, the actual value is USD 0.02, missing the estimate of USD 0.025.EBIT: As of FY2026 Q3, the actual value is USD 210.49 K.<h3>Third Quarter Fiscal 2026 Financial Highlights (Ended November 30, 2025)</h3><h4>Operational Metrics</h4><ul><li>Net Sales: Sono-Tek Corporation’s net sales for the quarter were $5.0 million, a 4% decrease compared to $5.2 million in the prior-year period.</li><li>Gross Profit: Gross profit increased 7% year over year to $2.5 million, up from $2.343 million in the prior-year quarter.</li><li>Gross Margin: Gross margin expanded to 50%, up from 45% in the prior-year quarter.</li><li>Operating Income: Operating income increased 61% to $319 thousand, compared to $198 thousand in the prior-year period.</li><li>Operating Margin: Operating margin was 6%, up from 4% in the prior-year period.</li><li>Net Income: Net income increased 24% to $340 thousand, compared to $274 thousand in the prior-year quarter.</li><li>Net Margin: Net margin was 7%, up from 5% in the prior-year period.</li><li>Operating Expenses: Total operating expenses were $2,193,269, compared to $2,145,562 in the prior-year period.<ul><li>Research and product development costs were $638,361.</li><li>Marketing and selling expenses were $927,300.</li><li>General and administrative costs were $627,608.</li></ul></li><li>Interest and Dividend Income: Interest and dividend income was $108,487, compared to $131,518 in the prior-year period.</li><li>Net Unrealized Gain/(Loss) on Marketable Securities: Net unrealized loss on marketable securities was - $658, compared to - $15,165 in the prior-year period.</li><li>Income Tax Expense: Income tax expense was $86,842, compared to $39,812 in the prior-year period.</li></ul><h4>Segment Revenue (Product Categories)</h4><ul><li>In-Line Coating Systems: Revenue increased sharply by 2,177%.</li><li>Multi-Axis Coating Systems: Revenue declined 53% year over year.</li><li>OEM Systems: Revenue increased 64%.</li><li>Fluxing Systems: Revenue increased 213%.</li></ul><h4>Segment Revenue (End Markets)</h4><ul><li>Medical Sales: Increased 27%.</li><li>Electronics/Microelectronics Sales: Increased 27%.</li><li>Industrial Sales: Increased 116%.</li><li>Alternative Energy Sales: Declined 35%.</li></ul><h3>First Nine Months Fiscal 2026 Financial Highlights (Ended November 30, 2025)</h3><h4>Operational Metrics</h4><ul><li>Net Sales: Net sales totaled $15.3 million, essentially flat year over year compared to $15.383 million in the prior-year period.</li><li>Gross Profit: Gross profit increased 6% to $7.8 million, up from $7.314 million in the prior-year period.</li><li>Gross Margin: Gross margin expanded to 51% from 48% in the prior-year period.</li><li>Operating Income: Operating income increased 69% to $1.22 million, compared to $722 thousand in the prior-year period.</li><li>Operating Margin: Operating margin was 8%, up from 5% in the prior-year period.</li><li>Net Income: Net income increased 32% to $1.25 million, compared to $946 thousand in the prior-year period.</li><li>Net Margin: Net margin was 8%, up from 6% in the prior-year period.</li><li>Operating Expenses: Total operating expenses were $6,542,998, compared to $6,591,860 in the prior-year period.<ul><li>Research and product development costs were $1,934,109.</li><li>Marketing and selling expenses were $2,656,804.</li><li>General and administrative costs were $1,952,085.</li></ul></li><li>Interest and Dividend Income: Interest and dividend income was $332,147, compared to $359,248 in the prior-year period.</li><li>Net Unrealized Gain/(Loss) on Marketable Securities: Net unrealized gain on marketable securities was $912, compared to $38,776 in the prior-year period.</li><li>Income Tax Expense: Income tax expense was $307,916, compared to $174,247 in the prior-year period.</li></ul><h4>Segment Revenue (Product Categories)</h4><ul><li>In-Line Coating Systems: Revenue increased by 126%.</li><li>Multi-Axis Coating Systems: Declined 46% year over year.</li><li>OEM Systems: Revenue increased 18%.</li><li>Fluxing Systems: Revenue increased 80%.</li></ul><h4>Segment Revenue (End Markets)</h4><ul><li>Medical Sales: Increased 37%.</li><li>Electronics/Microelectronics Sales: Decreased 9%.</li><li>Industrial Sales: Decreased 26%.</li><li>Alternative Energy Sales: Declined slightly by 2%.</li></ul><h3>Balance Sheet Highlights (as of November 30, 2025)</h3><ul><li>Cash and Cash Equivalents: $5,395,695.</li><li>Marketable Securities: $6,323,566.</li><li>Total Cash, Cash Equivalents, and Marketable Securities: $11.7 million.</li><li>Outstanding Debt: The company reported no outstanding debt.</li><li>Accounts Receivable: $4,411,663.</li><li>Inventories: $3,656,898.</li><li>Total Current Assets: $20,093,512.</li><li>Total Assets: $23,930,614.</li><li>Total Current Liabilities: $4,738,845.</li><li>Total Liabilities: $4,798,194.</li><li>Total Stockholders’ Equity: $19,132,420.</li></ul><h3>Unique Metrics</h3><ul><li>Backlog: Total backlog reached a record $12.26 million, increasing 16% year over year and 9% sequentially.</li></ul><h3>Outlook / Guidance</h3>Sono-Tek Corporation reiterates its guidance for the full fiscal year 2026, anticipating modest revenue growth. This outlook balances market adjustments due to governmental clean energy policy shifts and evolving tariff policies with positive demand growth in the medical device market. The company aims for consistent performance and long-term growth, supported by its strong balance sheet, record backlog, and expanding mix of high-ASP systems.

Sono-Tek | 8-K: FY2026 Q3 Revenue Misses Estimate at USD 5.004 M